相关实验视频
与Inclisiran相关的肌肉不良事件:FAERS数据库和门德尔随机化分析的数据挖掘
Dan Liu1, JiFang Liu1, Wei Mao2
1Department of Pharmacy, The first Affiliated Hospital of Army Medical University(Third Military Medical University), Chongqing, China.
Journal of cardiovascular pharmacology
|November 25, 2025
概括
新型siRNA药物Inclisiran显示了潜在的肌肉不良事件 (MAE). 长期安全监测对患者至关重要,特别是肌肉和肌痛,以确保及时诊断和管理.
科学领域:
- 药物监督 药物监督 药物监督
- 抗RNA干扰疗法RNA干扰疗法药物
- 心血管疾病药物安全性
背景情况:
- 英克利西兰是一种小干扰RNA (siRNA) 药物,用于降低脂质,但已报告肌肉不良事件 (MAE).
- 关于Inclisiran的MAE的长期安全数据尚不清楚.
- 了解Inclisiran的安全概况对于临床实践至关重要.
研究的目的:
- 调查与Inclisiran相关的潜在肌肉不良事件 (MAE).
- 评估Inclisiran对MAE的长期安全信号.
- 探索Inclisiran与肌肉骨系统疾病之间的因果关系.
主要方法:
- 使用食品和药物管理局不良事件报告系统 (FAERS) 数据库 (2021年12月 - 2024年12月).
- 使用不成比例分析 (ROR,BCPNN) 来挖掘MAE对Inclisiran的信号.
- 进行了分层分析和门德尔随机化 (MR) 来验证发现.
主要成果:
- 确定了因因克利西兰 (ROR:7.51) 的潜在MAE信号,肌肉和肌痛是关键问题.
- 英克利西兰的MAE信号强度低于他类药物,但高于其他PCSK9抑制剂.
- 核磁共振分析支持Inclisiran与肌肉骨系统疾病风险增加之间的潜在关联.
结论:
- 英克利西兰与肌肉不良事件 (MAE) 相关,需要持续的安全监测.
- 服用Inclisiran的患者需要对MAE进行警监测,包括肌肉和肌痛.
- 建议进行进一步的研究和临床监测,以确保Inclisiran的安全使用.
相关概念视频
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
136
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
136
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
241
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
241
01:29Therapeutic Drug Monitoring: Affecting Factors
183
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
183
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
387
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
387
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
895
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
895